CANDRIAM S.C.A. – Kymera Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$11.96M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+10.56%
quarter
Kymera Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +16.98% | 79.77K shares | 2.71M | $21.77 | 549.61K |
| Q2 2022 | share | Increase | +13.29% | 55.13K shares | -8.29M | $19.69 | 469.84K |
| Q1 2022 | share | Increase | +2.95% | 11.89K shares | -8.02M | $42.32 | 414.71K |
| Q4 2021 | share | Increase | +1.98% | 7.82K shares | 2.37M | $62.98 | 402.81K |
| Q3 2021 | share | Decrease | -3.89% | -16K shares | 3.26M | $58.74 | 394.99K |
| Q2 2021 | share | Increase | 0.00% | 410.99K shares | 19.93M | $48.5 | 410.99K |